Developers of both small- and large-molecule therapeutics urgently need to overcome drug formulation and delivery challenges in order to improve bioavailability and therapeutic performance. Small molecule drugs are challenged by poor solubility, and while enabled formulations can help with this, they often encounter stability hurdles of their own. Intravenous delivery of biologics sets limits on patient adherence and market success, so the next generation of delivery challenges will focus on subcutaneous and oral routes to broaden product pipelines and lengthen life cycles.

The 3rd annual Innovations in Drug Formulation & Delivery conference features never-before-heard case studies focusing on the industry’s most urgent needs for improving solubility and therapeutic performance!

Top Five Reasons to Attend

1. In-depth strategies for designing or transitioning your peptides and biologics into subcutaneous and oral delivery methods
2. Case studies for remaking your bioequivalence and bridging tests to more accurately capture the bioavailability of drugs after a change in delivery method
3. Analysis of the ideal manufacturing and process methods to improve stability, shelf life and bioavailability of amorphous solids
4. Training in the modeling techniques that predict performance of multiple formulations
5. An exclusive interactive workshop devoted to maximizing stability and life cycle access for subcutaneous and oral biologics

Who Should Attend

Pharmaceutical, biotech and medical device professionals responsible for:

This Program Will Also Be Of Interest To: